Epidemiology of schizophrenia: review of findings and myths
about
Aripiprazole versus haloperidol for people with schizophrenia and schizophrenia-like psychosesAripiprazole versus chlorpromazine for people with schizophrenia and schizophrenia-like psychosesAripiprazole versus sulpiride for people with schizophrenia and schizophrenia-like psychosesAripiprazole versus perphenazine for people with schizophrenia and schizophrenia-like psychosesClozapine for psychotic disorders in adults with intellectual disabilitiesZotepine versus placebo for schizophreniaClozapine for psychotic disorders in adults with intellectual disabilitiesMedicine. The future of psychiatric research: genomes and neural circuitsThe role of genetics in the etiology of schizophreniaMeta-analysis of oxidative stress in schizophrenia.Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locus.Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia.Neurophysiological Changes Induced by Chronic Toxoplasma gondii InfectionSchizophrenia in Thailand: prevalence and burden of disease.A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophreniaAntecedents and sex/gender differences in youth suicidal behavior.The association between negative symptoms, psychotic experiences and later schizophrenia: a population-based longitudinal studyMutation burden of rare variants in schizophrenia candidate genes.Advanced paternal age and risk of psychotic-like symptoms in adult offspring.Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses.Epidemiology and Treatment Guidelines of Negative Symptoms in Schizo-phrenia in Central and Eastern Europe: A Literature Review.Association of ARHGAP18 polymorphisms with schizophrenia in the Chinese-Han population.Psychiatric disorders in rapid-onset dystonia-parkinsonismA case study of SMART attributes: a qualitative assessment of generalizability, retention rate, and trial qualityEtiological and clinical features of childhood psychotic symptoms: results from a birth cohort.Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.Transcriptome study of differential expression in schizophrenia.Factors Associated with Adherence to the HEDIS Quality Measure in Medicaid Patients with Schizophrenia.A two-stage association study suggests BRAP as a susceptibility gene for schizophrenia.Acupuncture in the Treatment of a Female Patient Suffering from Chronic Schizophrenia and Sleep Disorders.Beyond the first episode: candidate factors for a risk prediction model of schizophrenia.Risk factors for the late-onset psychoses: a systematic review of cohort studies.Epidemiology of schizophrenia--an update with a focus on developing countries.The neurobiology of social environmental risk for schizophrenia: an evolving research field.Neighbourhood level social deprivation and the risk of psychotic disorders: a systematic review.Asenapine: A Review in Schizophrenia.The Gut-Brain Axis, BDNF, NMDA and CNS Disorders.Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies.A systematic review of sex and age factors in neuroleptic malignant syndrome diagnosis frequency.
P2860
Q24186218-282ED26F-F284-47FF-8722-2D6F96EF2BE3Q24186219-4FACF593-EAA2-4AA5-92DC-4EDA26215BB9Q24186220-56F3B04F-07F4-4CAD-82E4-2E2B0AED7B21Q24186223-90086970-158D-47E9-9492-E4F6FCF3124FQ24187048-4C03EA6F-C55E-4CEA-8AFE-AC9D4DCE28C4Q24201659-117DB699-95FE-4441-B9F4-41589BAD8EABQ24202342-A9EFD0C8-0D2E-4A59-A40D-E26660E93EF3Q24596789-B3BF7B16-402F-4DF1-8453-3DAD6DF9B13CQ28748800-33B1365E-8EA3-4252-99F9-5C61FB6D9941Q33601360-5D8BAA55-6DB5-4DD4-9B58-143FF02FE5BBQ33703868-1B802ABC-EF47-4288-879C-C8AAD3C87F0CQ33740241-04ED00D4-907A-4506-BC9E-7837DC0AB604Q33847259-1ADE7395-7D94-4ED3-A817-15AED3133367Q34114013-6DDA72F1-7D8E-4429-9684-4B7282906BDBQ34203368-8F22CB43-04D2-4B35-9750-690E4242C309Q34761282-DF3C4F1D-29C2-4F9E-82D7-08856D5AD8EEQ35154490-A1F1178A-5CA7-4DCF-8285-48AD22494787Q35651460-C960D281-1C9C-40B0-B280-A1232A83DBC6Q35755701-624C4159-ED87-4624-922D-1CC35CF97E18Q36110777-0E810D09-2707-4D69-92DF-B708F3A9FD79Q36232324-E9E0B57C-03A8-4B65-AF4D-05F5B08AF75BQ36338781-9582E14A-51A1-48C0-B0F4-7BC16F02C787Q36475263-3C22567C-1C63-4549-8D7C-DA7CB19A5BC2Q36972466-E83FB323-F8AB-4890-B948-AD8B12D784A1Q37180961-415AC619-0A25-4A2D-8714-B6E5C663AE6DQ37275549-22177496-28F7-4C9E-B247-C349F100D38CQ37327529-49423ACB-26DF-45F1-9414-3C3A0B94EE40Q37332227-BC8F7BF7-748C-4A5A-9297-5C46BB37493BQ37441407-FD71728C-14A9-4C6D-B700-599DC6653E7BQ37484359-5A0176DF-D313-48C7-9A00-CB8DC5313B16Q37557935-51070D11-778E-409E-BDAE-81EFBC05BE44Q37760933-821795CA-7896-4BE7-AA20-C1F4A1507492Q37862653-E18ED803-5F1F-42C2-AA31-06DC5B4D5C49Q38051430-FF1E9907-EC97-47A2-AD73-430F13032A2FQ38196727-C7C35893-FA4E-420D-8226-848E2A40ADF3Q38834172-A044EBB2-4029-475A-AFCB-2627AEA2E530Q38880899-AA0223E6-9D50-4231-AD44-B63DBD097190Q38935172-828FFE47-3710-4C08-A449-38DB7CAC21A3Q39009497-3B99AB6D-C06F-419F-93FE-7AFB209BF5C1Q39113019-A52D25A4-FF80-4881-BD82-0D6A6AAD7541
P2860
Epidemiology of schizophrenia: review of findings and myths
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Epidemiology of schizophrenia: review of findings and myths
@en
type
label
Epidemiology of schizophrenia: review of findings and myths
@en
prefLabel
Epidemiology of schizophrenia: review of findings and myths
@en
P2093
P2860
P1476
Epidemiology of schizophrenia: review of findings and myths
@en
P2093
Chuan-Yu Chen
Erick L Messias
William W Eaton
P2860
P304
P356
10.1016/J.PSC.2007.04.007
P577
2007-09-01T00:00:00Z